Hematogenous Pyelonephritis in Rats. IV. Relationship of Bacterial Species to the Pathogenesis and Sequelae of Chronic Pyelonephritis

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1959 Jul 1

PMID 13664797

Citations 12

Authors

A P Shapiro

A I BRAUDE

J Siemienski

Affiliations

Soon will be listed here.

Citing Articles

EXPERIMENTAL PYELONEPHRITIS: OBSERVATIONS ON MIXED INFECTION.

Rocha H, DEALMEIDA S Yale J Biol Med. 1965; 37:313-8.

PMID: 14282814 PMC: 2604714.

PATHOGENESIS OF CHRONIC PYELONEPHRITIS. II. EFFECT OF REPETITIVE INFECTION.

SOMMERS S, Gonick H, KALMANSON G, Guze L Am J Pathol. 1964; 45:729-39.

PMID: 14223578 PMC: 1907146.

Increased susceptibility to pyelonephritis during acute hypertension by angiotensin II and norepinephrine.

Jones R, Shapiro A J Clin Invest. 1963; 42:179-86.

PMID: 14029543 PMC: 289266. DOI: 10.1172/JCI104704.

Retrograde Proteus pyelonephritis in rats. Bacteriologic, pathologic and fluorescent-antibody studies.

COTRAN R, Vivaldi E, ZANGWILL D, KASS E Am J Pathol. 1963; 43:1-31.

PMID: 14023346 PMC: 1949723.

Experimental pyelonephritis. The effect of chronic infection on the blood pressure in the rat.

HEPTINSTALL R Br J Exp Pathol. 1962; 43:333-9.

PMID: 13906609 PMC: 2094688.

References

HEPTINSTALL R, Gorrill R . Experimental pyelonephritis and its effect on the blood pressure. J Pathol Bacteriol. 1955; 69(1-2):191-8. DOI: 10.1002/path.1700690126. View

BRAUDE A, Shapiro A, Siemienski J . Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method. J Clin Invest. 1955; 34(10):1489-97. PMC: 438724. DOI: 10.1172/JCI103200. View

Kincaid-Smith P . Vascular obstruction in chronic pyelonephritic kidneys and its relation to hypertension. Lancet. 1955; 269(6903):1263-9. DOI: 10.1016/s0140-6736(55)93054-3. View

Beeson P . Factors in the pathogenesis of pyelonephritis. Yale J Biol Med. 1955; 28(2):81-104. PMC: 2599723. View

Bing J . Effects of ether anaesthesia on the results of indirect determination of blood pressure in the rat. Acta Pharmacol Toxicol (Copenh). 1956; 12(3):285-93. DOI: 10.1111/j.1600-0773.1956.tb01388.x. View

KOLETSKY S . Necrotizing vascular disease in rat. II. Role of sodium chloride. AMA Arch Pathol. 1957; 63(4):405-10. View

Kleeman C, EPSTEIN F . An illustrative case of chronic pyelonephritis with persistently hypotonic urine. Am J Med. 1957; 23(3):488-92. DOI: 10.1016/0002-9343(57)90327-3. View

GOLDBLATT H . Pathogenesis of malignant hypertension. Circulation. 1957; 16(5):697-9. DOI: 10.1161/01.cir.16.5.697. View

JACKSON G, POIRIER K, GRIEBLE H . Concepts of pyelonephritis; experience with renal biopsies and long-term clinical observations. Ann Intern Med. 1957; 47(6):1165-83. DOI: 10.7326/0003-4819-47-6-1165. View

10.

Shapiro A, MELHADO J . Factors affecting development of hypertensive vascular disease after renal injury in rats. Proc Soc Exp Biol Med. 1957; 96(3):619-23. DOI: 10.3181/00379727-96-23556. View

11.

DUSTAN H, MASSON G . Contribution of the adrenal cortex to renal and renoprival hypertension. Circulation. 1958; 17(4, Part 2):765-7. DOI: 10.1161/01.cir.17.4.765. View

12.

BRAUDE A, Shapiro A, Siemienski J . Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyeionephritis. J Bacteriol. 1959; 77(3):270-80. PMC: 290365. DOI: 10.1128/jb.77.3.270-280.1959. View

13.

BIRCHALL R, Alexander J . Medical aspects of pyelonephritis. Medicine (Baltimore). 1950; 29(1):1-28. DOI: 10.1097/00005792-195002000-00001. View